VRNA

Verona Pharma
VRNA

Overview Fund Trends Analyst Outlook
Delisted

VRNA was delisted on the 6th of October, 2025.

Back to rankings

95 hedge funds and large institutions have $1.22B invested in Verona Pharma in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 39 increasing their positions, 21 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
+7
Holders Change %
+7.95%
% of All Funds
1.52%
Holding in Top 10
14
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-12.5%
% of All Funds
0.22%
New
22
Increased
39
Reduced
21
Closed
13
Calls
$3.52M
Puts
$2.14M
Net Calls
+$1.39M
Net Calls Change
-$22.1M

Top Buyers

1
CG
Carlyle Group
District of Columbia
+$49.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$48.1M
3
WP
Woodline Partners
California
+$30M
4
PBA
Paradigm Biocapital Advisors
New York
+$19.3M
5
NIP
Nicholas Investment Partners
California
+$18.9M

Top Sellers

1
PA
Perceptive Advisors
New York
-$43.1M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$6.34M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.32M
4
O
OrbiMed
New York
-$6.26M
5
MFS
Mirabella Financial Services
United Kingdom
-$5.83M
Name Holding Trade Value Shares
Change 		Shares
Change %
RCM
1
RA Capital Management
Massachusetts
$127M – – –
NMC
2
NEA Management Company
Maryland
$112M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$91.7M +$48.1M +2,393,033 +110%
O
4
OrbiMed
New York
$85.6M -$6.26M -311,598 -7%
VC
5
Vivo Capital
California
$85.3M – – –
Wellington Management Group
6
Wellington Management Group
Massachusetts
$66.1M -$1.1M -54,897 -2%
DTC
7
Deep Track Capital
Connecticut
$64M – – –
FFM
8
Fairmount Funds Management
Pennsylvania
$62.8M +$5.06M +251,903 +9%
FLSM
9
Frazier Life Sciences Management
California
$59.1M +$2.58M +128,629 +5%
PA
10
Perceptive Advisors
New York
$54.9M -$43.1M -2,146,929 -44%
OCA
11
Octagon Capital Advisors
New York
$49.6M – – –
CG
12
Carlyle Group
District of Columbia
$49.3M +$49.3M +2,457,500 New
WP
13
Woodline Partners
California
$35M +$30M +1,494,264 +598%
ACM
14
Aisling Capital Management
New York
$22.4M -$4.36M -217,133 -16%
Jennison Associates
15
Jennison Associates
New York
$20.7M -$32.7K -1,629 -0.2%
PBA
16
Paradigm Biocapital Advisors
New York
$19.3M +$19.3M +962,361 New
NIP
17
Nicholas Investment Partners
California
$18.9M +$18.9M +941,300 New
APM
18
Avidity Partners Management
Texas
$17.6M +$17.6M +878,800 New
SB
19
Samsara BioCapital
California
$14M – – –
Millennium Management
20
Millennium Management
New York
$11.1M +$4.75M +236,709 +75%
MFS
21
Mirabella Financial Services
United Kingdom
$10.4M -$5.83M -16,540 -36%
PHP
22
Parkman Healthcare Partners
Connecticut
$9.8M +$1.48M +73,547 +18%
ABG
23
Ally Bridge Group
New York
$9.79M +$9.79M +487,631 New
AAA
24
Affinity Asset Advisors
New York
$9.09M +$2.82M +140,323 +45%
Two Sigma Investments
25
Two Sigma Investments
New York
$8.13M -$2.4M -119,550 -23%
1
2 3 4 5